CN Patent

CN109942582B — 一种靶向原肌球蛋白激酶trk融合蛋白的pet探针及其合成与应用

Assigned to Shanghai University of Medicine and Health Sciences · Expires 2020-12-01 · 5y expired

What this patent protects

本发明涉及一种靶向原肌球蛋白激酶TRK融合蛋白的PET探针及其合成与应用。PET探针，其分子结构如下： 与现有技术相比，本发明研发出了新型的TRK PET探针，具有TRK特异性，用于探测TRK融合蛋白在肿瘤组织中的表达，从而为临床检查提供可靠的诊断与分子表型的数据。

USPTO Abstract

本发明涉及一种靶向原肌球蛋白激酶TRK融合蛋白的PET探针及其合成与应用。PET探针，其分子结构如下： 与现有技术相比，本发明研发出了新型的TRK PET探针，具有TRK特异性，用于探测TRK融合蛋白在肿瘤组织中的表达，从而为临床检查提供可靠的诊断与分子表型的数据。

Drugs covered by this patent

Patent Metadata

Patent number
CN109942582B
Jurisdiction
CN
Classification
—
Expires
2020-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai University of Medicine and Health Sciences
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.